Cantitate/Preț
Produs

Thoracic Oncology: Cancer Treatment and Research, cartea 105

Editat de David S. Ettinger
en Limba Engleză Hardback – 31 dec 2000
In the United States alone, the incidence of new cases of thoracic neoplasms is over 180,000. Each year, over 170,000 individuals are expected to die of their cancer. Lung cancer is the most common of the thoracic neoplasms. It is the leading cause of cancer death in both men and women, accounting for 28% of all cancer deaths in the United States.
Thoracic Oncology provides an up-to-date and concise review of the various thoracic neoplasms and offers a better understanding of the biology, natural history, diagnosis and treatment of these malignancies. This book will be of particular interest to clinicians interested in thoracic neoplasms, to better understand and treat them.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 70808 lei  6-8 săpt.
  Springer Us – 24 oct 2012 70808 lei  6-8 săpt.
Hardback (1) 127132 lei  6-8 săpt.
  Springer Us – 31 dec 2000 127132 lei  6-8 săpt.

Din seria Cancer Treatment and Research

Preț: 127132 lei

Preț vechi: 133823 lei
-5% Nou

Puncte Express: 1907

Preț estimativ în valută:
24338 25298$ 20179£

Carte tipărită la comandă

Livrare economică 05-19 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792372486
ISBN-10: 0792372484
Pagini: 404
Ilustrații: XIV, 404 p.
Dimensiuni: 155 x 235 x 24 mm
Greutate: 0.77 kg
Ediția:2001
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Table of Contents List of Contributors.- I Lung Cancer.- I. Biological Considerations in Lung Cancer.- II. The Epidemiology of Lung Cancer.- III. Staging and Prognosis in Lung Cancer.- II Non-Small Cell Lung Cancer.- IV. Surgery for Non-Small Cell Lung Cancer.- V. Radiation Therapy for NSCLC.- V. Combined Modality Therapy for Early Stage Operable NSCLC.- VI. Chemoradiation in Locally Advanced NSCLC.- VIII. Lung Cancer: Therapeutic Options for Stage IV NSCLC and Recurrent NSCLC.- III Small Cell Lung Cancer.- IX. Therapy of Limited Stage SCLC.- X. Treatment of Extensive Stage SCLC.- IV Mediastinal Tumors.- XI. Thymic Malignancies.- XII. Germ Cell Neoplasms and Other Malignancies of the Mediastinum.- V Malignancies of the Pleura.- XIII. Malignant Pleural Mesothelioma.- VI Esophogeal Cancer.- XIV. Epidemiology, Diagnosis and Staging of Esophageal Cancer.- XV. Therapy for Esophageal Cancer.